Mustang Bio Inc (MBIO)
0.316
+0.02
(+5.30%)
USD |
NASDAQ |
May 17, 16:00
0.316
0.00 (0.00%)
After-Hours: 20:00
Mustang Bio 1 Year Total Returns (Daily): -92.93% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | -92.93% |
May 16, 2024 | -93.09% |
May 15, 2024 | -93.64% |
May 14, 2024 | -94.24% |
May 13, 2024 | -94.42% |
May 10, 2024 | -94.27% |
May 09, 2024 | -93.98% |
May 08, 2024 | -93.21% |
May 07, 2024 | -93.27% |
May 06, 2024 | -92.87% |
May 03, 2024 | -92.17% |
May 02, 2024 | -92.69% |
May 01, 2024 | -93.61% |
April 30, 2024 | -94.15% |
April 29, 2024 | -94.41% |
April 26, 2024 | -91.87% |
April 25, 2024 | -90.90% |
April 24, 2024 | -91.68% |
April 23, 2024 | -91.52% |
April 22, 2024 | -91.98% |
April 19, 2024 | -91.54% |
April 18, 2024 | -90.34% |
April 17, 2024 | -88.54% |
April 16, 2024 | -89.79% |
April 15, 2024 | -88.94% |
Date | Value |
---|---|
April 12, 2024 | -81.99% |
April 11, 2024 | -82.35% |
April 10, 2024 | -83.76% |
April 09, 2024 | -79.88% |
April 08, 2024 | -79.21% |
April 05, 2024 | -77.57% |
April 04, 2024 | -82.52% |
April 03, 2024 | -83.18% |
April 02, 2024 | -81.45% |
April 01, 2024 | -80.91% |
March 28, 2024 | -80.84% |
March 27, 2024 | -82.60% |
March 26, 2024 | -82.25% |
March 25, 2024 | -81.69% |
March 22, 2024 | -80.28% |
March 21, 2024 | -80.27% |
March 20, 2024 | -78.29% |
March 19, 2024 | -80.51% |
March 18, 2024 | -80.61% |
March 15, 2024 | -84.10% |
March 14, 2024 | -83.16% |
March 13, 2024 | -84.21% |
March 12, 2024 | -82.96% |
March 11, 2024 | -81.36% |
March 08, 2024 | -82.65% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-94.42%
Minimum
May 13 2024
81.95%
Maximum
Mar 15 2021
-40.25%
Average
-42.54%
Median
Aug 28 2019
1 Year Total Returns (Daily) Benchmarks
Fortress Biotech Inc | -81.03% |
Avinger Inc | -58.13% |
AIM ImmunoTech Inc | -19.40% |
Protalix BioTherapeutics Inc | -51.69% |
Armata Pharmaceuticals Inc | 107.2% |